Prospects for using plant extracts to correct fat and carbohydrate metabolism disorders


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Currently, there is a steady increase in the incidence of diseases, the basis for which is associated carbohydrate and fat metabolism disorders (metabolic syndrome, type 2 diabetes mellitus, obesity, dyslipidemia, and non-alcoholic fatty liver disease). Despite the drugs available in clinical practice for the correction of fat and carbohydrate metabolism disorders, there is a high demand for new effective medicines that would expand the existing arsenal of drugs with this kind of a therapeutic effect. Among the traditional sources of biologically active substances, such as chemical synthesis, biotechnological synthesis, and design of plant-based drugs, the latter area is of great interest due to the variety of active ingredients that are constituents of medicinal plants. The final product of extracts from medicinal plants can be phytopreparations, phytoadjuvants (plant extracts that are able to change the pharmacokinetic and/or pharmacodynamic properties of phytopreparations), and phytonutrients, the components of medicinal and food plants, which ensure optimal functioning of various body systems.

Full Text

Restricted Access

About the authors

Sergey Vladimirovich Okovityi

Saint Petersburg State Chemical Pharmaceutical University

Email: okovityy@mail.ru; Sergey.Okovity@pharminnotech.com

Vera Tsesarevna Bolotova

Saint Petersburg State Chemical Pharmaceutical University

Email: vera.bolotova@pharminnotech.com

Natalia Askoldovna Anisimova

Saint Petersburg State Chemical Pharmaceutical University

Email: natalia.anisimova@pharminnotech.com

Dmitry Yurevich Ivkin

Saint Petersburg State Chemical Pharmaceutical University

Email: dmitry.ivkin@pharminnotech.com

Irina Alexandrovna Titovich

Saint Petersburg State Chemical Pharmaceutical University

Email: irina.titovich@pharminnotech.com

Yuriy Igorevich Sysoev

Saint Petersburg State Chemical Pharmaceutical University

Email: susoyev92@mail.ru

Svetlana Mikhailovna Napalkova

Saint Petersburg State Chemical Pharmaceutical University

Email: svet-na@mail.ru

References

  1. Falzon C.C., Balabanova A. Phytotherapy: an introduction to herbal medicine. Prim. Care, 2017; 44(2): 217-27. doi: 10.1016/j.pop.2017.02.001
  2. Хотим Е.Н., Жигальцов А.М., Кумара Аппаду. Некоторые аспекты современной фитотерапии. Журнал Гродненского государственного медицинского университета, 2016; 3: 128-31. [Khotim E.N., Zhigal'tsov A.M., Kumara Appadu. Some aspects of modern herbal medicine. Zhurnal Grodnenskogo gosudarstvenno-go meditsinskogo universitetata, 2016; 3: 128-31 (in Russian)].
  3. El-Abhar H.S., Schaalan M.F. Phytotherapy in diabetes: review on potential mechanistic perspectives. World J. Diabetes, 2014; 5 (2): 176-97. https://doi.org/10.4239/wjd.v5.i2.176
  4. Kadan S., Saad B., Sasson Y., Zaid H. In vitro evaluations of cytotoxicity of eight antidiabetic medicinal plants and their effect on GLUT4 translocation. Evid. Based Complement. Alternat. Med., 2013; 2013: 549345. https://doi.org/10.1155/2013/549345
  5. Rahimzadeh M., Jahanshahi S., Moein S., Moein M.R. Evaluation of alpha-amylase inhibition by Urticadioica and Juglansregia extracts. Iran. J. Basic Med. Sci., 2014; 17 (6): 465-9.
  6. Ramirez G., Zavala M., Perez J., Zamilpa A. In vitro screening of medicinal plants used in Mexico as antidiabetics with glucosidase and lipase inhibitory activities. Evid. Based Complement. Alternat. Med., 2012; 2012: 701261. https://doi. org/10.1155/2012/701261
  7. Wang L., Waltenberger B., Pferschy-Wenzig E.M. et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARy): a review. Biochem. Pharmacol., 2014; 92 (1): 73-89. https://doi.org/10.1016/j.bcp.2014.07.018
  8. Makarova E., Gornas P., Konrade I. et al. Acute anti-hyper-glycaemic effects of an unripe apple preparation containing phlorizin in healthy volunteers: a preliminary study. J. Sci. Food Agric., 2015; 95 (3): 560-8. https://doi.org/10.1002/jsfa.6779
  9. Shirosaki M., Koyama T., Yazawa K. Apple leaf extract as a potential candidate for suppressing postprandial elevation of the blood glucose level. J. Nutr. Sci. Vitaminol., 2012; 58 (1): 63-7. https://doi.org/10.3177/jnsv.58.63
  10. Uddin M.N., Sharma G., Yang J.L. et al. Olean anetriter-penes as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Camelliajaponica. Phytochemistry, 2014; 103: 99-106. doi: 10.1016/j.phytochem.2014.04.002
  11. Lian L.H., Wu Y.L., Song S.Z. et al. Gentianamanshurica Kitagawa reverses acute alcohol-induced liver steatosis through blocking sterol regulatory element-binding protein-1 maturation. J. Agric. Food Chem., 2010; 58(24): 13013-9. https://doi. org/10.1021/jf103976y
  12. Zhang J., Xue J., Wang H. et al. Osthole improves alcohol-induced fatty liver in mice by reduction of hepatic oxidative stress. Phytotherapy Research., 2011; 25 (5): 638-43. doi: 10.1002/ptr.3315
  13. Ajmo J.M., Liang X., Rogers C.Q. et al. Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol., 2008; 295(4): G833-G842. https://doi. org/10.1152/ajpgi.90358.2008
  14. Duval F., Moreno-Cuevas J.E., Gonzalez-Garza M.T. et al. Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells. Adv. Pharmacol. Sci., 2014; 2014: 373295. https://doi. org/10.1155/2014/373295
  15. Marcolin E., Forgiarini L.F., Rodrigues G. et al. Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. Basic Clin. Pharmacol. Toxicol., 2013; 112 (6): 385-91. https:// doi.org/10.1111/bcpt.12049
  16. Yin M., Bradford B.U., Wheeler M.D. et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol., 2001; 166 (7): 4737-42. https://doi.org/10.4049/jimmunol.166.7.4737
  17. Ajazuddin, Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia, 2010;81 (7): 680-9. https://doi.org/10.1016/j.fitote.2010.05.001
  18. Dudhatra G.B., Mody S.K., Awale M.M. et al. A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Scientific World Journal, 2012; 2012: 637953. https://doi. org/10.1100/2012/637953
  19. Ajazuddin, Alexander A., Qureshi A. et al. Role of herbal bioactives as a potential bioavailability enhancer for active pharmaceutical ingredients. Fitoterapia, 2014; 97: 1-14. https://doi. org/10.1016/j.fitote.2014.05.005
  20. Randhawa G.K., Kullar J.S., Rajkumar. Bioenhancers from mother nature and their applicability in modern medicine. Int. J. App. Basic Med. Res., 2011; 1 (1): 5-10. https://doi. org/10.4103/2229-516X.81972
  21. Singh S., Tripathi J.S., Rai N.P. An appraisal of the bioavailability enhancers in Ayurveda in the light of recent pharmacological advances. Ayu, 2016; 37 (1): 3-10. https://doi. org/10.4103/ayu.AYU_11_15
  22. Barzaghi N. Pharmacokinetic studies on IdB 1016, a sily-bin-phosphatidylcholine complex, in healthy human subjects. Eur. J. Drug Metab. Pharmacokinet.,1990; 15 (4): 333-8. https:// doi.org/10.1007/BF03190223
  23. Khan J., Alexander A., Ajazuddin et al. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J. Control. Release, 2013; 168 (1): 50-60. https://doi.org/10.1016/j. jconrel.2013.02.025
  24. Bagchi D. Nutraceuticals and functional foods regulations in the United States and around the world. Toxicology, 2006; 221 (1): 1-3. https://doi.org/10.1016/j.tox.2006.01.001
  25. Hernandez-Rodas M.C., Valenzuela R., Videla L.A. Relevant aspects of nutritional and dietary interventions in nonalcoholic fatty liver disease. Int. J. Mol. Sci., 2015; 16 (10): 2516898. https://doi.org/10.3390/ijms161025168
  26. Киселева Т.Л., Тутельян В.А., Кочеткова А.А., Киселева М.А. Интегративные подходы к научно обоснованной фитотерапии сахарного диабета и созданию специализированных пищевых продуктов для больных сахарным диабетом 2 типа. Курский научно-практический вестник «Человек и его здоровье», 2015; 3: 110-20.
  27. Akkarachiyasit S., Charoenlertkul P., Yibchok-Anun S., Adisakwattana S. Inhibitory activities of cyanidin and its glycosides and synergistic effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Int. J. Mol. Sci., 2010; 11 (9): 3387-96. https://doi.org/10.3390/ijms11093387
  28. Pozo-Guisado E., Alvarez-Barrientos A., Mulero-Navarro S. et al. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol., 2002; 64 (9): 1375-86.
  29. Qin Y., Xia M., Ma J. et al. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am. J. Clin. Nutr., 2009; 90 (3): 485-92. https://doi.org/10.3945/ajcn.2009.27814
  30. Santamarina A.B., Carvalho-Silva M., Gomes L.M. et al. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. J. Nutr. Biochem., 2015; 26 (11): 1348-56. https:// doi.org/10.1016/j.jnutbio.2015.07.002

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies